Where is Noviotic located?

Noviotic is headquartered in Plovdiv, Bulgaria.

Where does Noviotic rank among its competitors?

Noviotic ranks 137th amongst 180 active competitors, of which 31 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was OptiBiotix Health, which secured $1.01M in May, 2025.

Who are the top competitors of Noviotic?

Noviotic's top competitors include Pendulum, Harmless Harvest and OptiBiotix Health. Among them, OptiBiotix Health secured the most recent funding round in May, 2025.

Noviotic - 2026 Company Profile, Funding & Competitors

Company Details

Developer of probiotic strains and probiotic supplements. The company offer a comprehensive collection of probiotic strains, combining a combination of scientifically proven prebiotics, probiotics, and postbiotics.

Website: www.noviotic.com/
Email ID: *****@noviotic.com

Key Metrics

Founded Year

2021

Location

Plovdiv, Bulgaria

Stage

Funding Raised

Investors

Vitosha Venture Partners

Ranked

137^th among 180 active competitors

Similar Companies

Pendulum & 182 more

View Noviotic's full profile

Noviotic is a funded company. Noviotic has 1 institutional investor.

View details of Noviotic's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Noviotic include Pendulum, Harmless Harvest and OptiBiotix Health. Here is the list of Top 10 competitors of Noviotic, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Pendulum 2012, San Francisco (United States), Series C	Manufacturer of medical probiotics	$111M	Meritech, Sequoia Capital & 13 others	66/100
2nd	Harmless Harvest 2009, San Francisco (United States), Acquired	Organic coconut water and beverages, ethically sourced and sustainably produced	$30M	Danone Manifesto Ventures, Mousse Partners ... & 1 others	57/100
3rd	OptiBiotix Health 2012, York (United Kingdom), Public	Developer of microbial strains for the treatment of human metabolic diseases	-	Seneca EIS Portfolio Fund, Mercia & 2 others	55/100
4th	The Good Bug 2022, Mumbai (India), Series B	Provider of personalised synbiotic supplements and fermented products for gut health	$20.6M	Fireside Ventures, Sai Global India Fund & 9 others	55/100
5th	Oragenics 1996, Tampa (United States), Public	Developer of novel treatments for infectious diseases and oral mucositis as well as probiotics for oral health	-	Third Security, Precigen & 3 others	53/100
6th	One bio 2015, New York City (United States), Series A	Online tools for partner management and opportunity screening.	$27M	Alpha Edison, Skyviews Life Science & 8 others	50/100
7th	Velbiom Probiotics 2015, Bengaluru (India), Series A	Provider of probiotic supplements for multiple ailments	$5.65M	Tenshi Life Sciences, Strides Pharma Science ... & 20 others	49/100
8th	Anabio Technologies 2018, Bengaluru (India), Funding Raised	Developed probiotic-based products and technology for health improvement	-	Europa, C-CAMP & 3 others	49/100
9th	Probi 1991, Lund (Sweden), Acquired	Developer of probiotic strains and health solutions	-	Eiffel Investment Group	49/100
10th	BioGaia 1990, Stockholm (Sweden), Public	Developer of probiotic food supplements for adults and babies	-	Centrecourt	49/100
137th	Noviotic 2021, Plovdiv (Bulgaria), Funding Raised	Developer of probiotic strains and probiotic supplements	-	Vitosha Venture Partners	22/100